Flosonics Medical closes US$14 million financing round

1 minute read
02 February 2021

On February 2, 2021, Flosonics Medical announced the close of a US$14 million funding round led by Arboretum Ventures and including participation from existing investors iGan Partners and Genesys Capital. 

Flosonics Medical is a Canadian medical device company focused on non-invasive hemodynamic monitoring, headquartered in Sudbury, Ontario. Arboretum Ventures is a venture capital firm, headquartered in Ann Arbor, Michigan, specializing in the healthcare sector. 

Gowling WLG advised Flosonics Medical with respect to this investment with a team that included Todd Bissett, Andrew Griffin and Marco Wai.


NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.